Evidence map›Paper›PMID 31870104›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2019

Role of Inflammatory Markers in Prognosis of Oral Squamous Cell Carcinoma.

Thinali Sousa Dantas, Paulo Goberlânio de Barros Silva, Maria Elisa Quezado Lima Verde, Aloísio de Lima Ribeiro Junior, Maria do Perpétuo Socorro Saldanha Cunha, Mário Rogério Lima Mota, Ana Paula Negreiros Nunes Alves, Renata Ferreira de Carvalho Leitão, Fabrício Bitu Sousa

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. PMS2: a potential prognostic protein marker in oral squamous cell carcinoma.Medicina oral, patologia oral y cirugia bucal · 2021
    Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Thinali Sousa DantasDivision of Oral Pathology, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID 0000-0003-2543-3315
Paulo Goberlânio de Barros SilvaDivision of Oral Pathology, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID 0000-0002-1513-9027
Maria Elisa Quezado Lima VerdeDivision of Oral Pathology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Aloísio de Lima Ribeiro JuniorDepartment of Dentistry, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Maria do Perpétuo Socorro Saldanha CunhaCeará School of Oncology, Hospital Haroldo Juaçaba, Fortaleza, Ceará, Brazil.
Mário Rogério Lima MotaDivision of Oral Pathology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Ana Paula Negreiros Nunes AlvesDivision of Oral Pathology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Renata Ferreira de Carvalho LeitãoDepartment of Morphology, Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Fabrício Bitu SousaDivision of Oral Pathology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Universidade Federal do Ceará · BRUnichristus · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis estudie evaluated the immunostaining of cytokines in oral carcinoma, in tissue of margin of surgical resecate (MSR) and metastatic lymph nodes, as well as their role in patient prognosis.

methodsA retrospective study was carried out in patients with oral squamous cell carcinomas, and sociodemographic and clinical-pathological data were evaluated. In addition, surgical site analysis of the patients was conducted by immunohistochemistry, using a tissue microarray for inflammatory (Tumor Necrosis Factor-alpha, Interleukin-1beta, Interleukin-6, interleukin-10), transcription NF-kappa B and CD68 markers. Immunoexpression was assessed qualitatively and quantitatively using ImageJ software, and data were correlated with the prognostic factors and patient survival rates.

resultsThere was a greater immunoexpression of inflammatory and CD68 cytokines in primary tumour and lymph node metastasis than in MSR. In a multinomial logistic regression model, patients with low education (p = 0.041) and a high histoscore for TNF-α (p = 0.021) showed a survival rate of 15.64 (95% CI = 1.13-217.24) and 6.81 (95% CI = 1.02-105.96).

conclusionTherefore, despite there is an increased immunoexpression of cytokines in the primary tumour, only TNF-α was the inflammatory cytokine that influenced the survival of patients with oral cancer.

Indexed as

Carcinoma, Squamous CellCross-Sectional StudiesEpithelial CellsFemaleHumansImmunohistochemistryLymphatic MetastasisLymph NodesMaleMiddle AgedMouth NeoplasmsPrognosisRetrospective StudiesSurvival RateTumor Necrosis Factor-alphaTumor Necrosis Factor-alphaInflammationSquamous Cell CarcinomasurvivalTumor Necrosis Factor-alpha

Identifiers

PMID31870104
PMCPMC7173367
OpenAlexW2998082466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.